US$ 20.88
glp-1 receptor agonists PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Explained for
Description
[Article] [PubMed]51

But I do not want to lose weight

novel peptides like retatrutide, GLP-3) is under development ( [35] )

4 Global estimates also reveal substantial regional variation in adolescent obesity prevalence, reflecting differences in socioeconomic status, urbanization, dietary patterns, and physical activity levels (Table 1)

By route of administration, the parenteral segment contributed the highest market share of approximately 88% in 2025

GLP-1 weight loss injections are intended to support healthy weight loss
